Three countries, one diagnosis

The American system is overbuilt and underaligned. There is a specialist for every organ, an imaging centre on every block, and an insurance code for every breath you take — and yet the best predictor of whether you’ll be healthy at sixty is still your zip code. The system is a marvel of capability and a tragedy of incentives. Nobody is paid to keep you well. Almost everybody is paid to treat you when you aren’t.

The Canadian system is gentler and slower. It is genuinely committed to equity, which I admire, and genuinely allergic to measurement, which I don’t. You will not go bankrupt for a heart attack here. You may also wait nine months for an MRI to find out you didn’t need one. We confuse access with outcomes — and assume that because care is universal, it must also be working. Some of it is. A lot of it isn’t, and there is no instrument on the dashboard that would tell you which is which.

The Indian system is the inverse: high-velocity, low-coordination, and shockingly affordable at the per-procedure level. The miracle is that it works at all. The tragedy is that it works almost entirely on volume. A diabetic in a tier-one Indian city can see a specialist tomorrow. Whether anyone is tracking her HbA1c trajectory across the next five years — whether anyone is responsible for whether she’s still walking unaided at seventy — that is a different question, and the answer is almost always nobody.

Three countries, three textures, one underlying diagnosis: healthcare is built to manage disease, not to build health. The feedback loops point the wrong way. Volume is rewarded; outcomes aren’t watched. Until the loop closes — until the system pays attention to whether you are actually getting better — every other reform is decoration.